ADAMTS9 and gastric cancer: Mechanistically, ADAMTS9 was shown to inhibit the oncogenic Akt/mTOR/HIF1α signaling pathway that results in reduced proliferation, induction of apoptosis and inhibition of angiogenesis in gastric cancer.